Kalow W - Search Results

1

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, Cola P, Howard A, Badri F, Nöthen MM, Kalow W, Kennedy JL. Masellis M, et al. Among authors: kalow w. Neuropsychopharmacology. 1998 Aug;19(2):123-32. doi: 10.1016/S0893-133X(98)00007-4. Neuropsychopharmacology. 1998. PMID: 9629566

2

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.

Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, Potkin SG, Alva G, Kalow W, Macciardi FM, Kennedy JL. Basile VS, et al. Among authors: kalow w. Mol Psychiatry. 2000 Jul;5(4):410-7. doi: 10.1038/sj.mp.4000736. Mol Psychiatry. 2000. PMID: 10889552

3

CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.

Ozdemir V, Kalow W, Posner P, Collins EJ, Kennedy JL, Tang BK, Albers LJ, Reist C, Roy R, Walkes W, Afra P. Ozdemir V, et al. Among authors: kalow w. J Clin Psychopharmacol. 2001 Aug;21(4):398-407. doi: 10.1097/00004714-200108000-00007. J Clin Psychopharmacol. 2001. PMID: 11476124 Clinical Trial.

4

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.

Ozdemir V, Kalow W, Okey AB, Lam MS, Albers LJ, Reist C, Fourie J, Posner P, Collins EJ, Roy R. Ozdemir V, et al. Among authors: kalow w. J Clin Psychopharmacol. 2001 Dec;21(6):603-7. doi: 10.1097/00004714-200112000-00011. J Clin Psychopharmacol. 2001. PMID: 11763009

5

CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited.

Ozdemir V, Bertilsson L, Miura J, Carpenter E, Reist C, Harper P, Widén J, Svensson JO, Albers LJ, Kennedy JL, Endrenyi L, Kalow W. Ozdemir V, et al. Among authors: kalow w. Pharmacogenet Genomics. 2007 May;17(5):339-47. doi: 10.1097/FPC.0b013e32801a3c10. Pharmacogenet Genomics. 2007. PMID: 17429316 Clinical Trial.

6

Variability of acetaminophen metabolism in Caucasians and Orientals.

Patel M, Tang BK, Kalow W. Patel M, et al. Among authors: kalow w. Pharmacogenetics. 1992 Feb;2(1):38-45. doi: 10.1097/00008571-199202000-00007. Pharmacogenetics. 1992. PMID: 1302042

7

Pharmacogenetics in biological perspective.

Kalow W. Kalow W. Pharmacol Rev. 1997 Dec;49(4):369-79. Pharmacol Rev. 1997. PMID: 9443163 Review.

8

The Pennsylvania State University College of Medicine 1990 Bernard B. Brodie Lecture. Pharmacogenetics: past and future.

Kalow W. Kalow W. Life Sci. 1990;47(16):1385-97. doi: 10.1016/0024-3205(90)90517-u. Life Sci. 1990. PMID: 2250557 Review. No abstract available.

9

The relation of plasma cholinesterases to response to clinical doses of succinylcholine.

Kalow W. Kalow W. Can J Anaesth. 2008 Dec;55(12):860-68. doi: 10.1007/BF03034058. Can J Anaesth. 2008. PMID: 19050090 No abstract available.

10

Intramuscular desferrioxamine in patients with Alzheimer's disease.

Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF. Crapper McLachlan DR, et al. Among authors: kalow w. Lancet. 1991 Jun 1;337(8753):1304-8. doi: 10.1016/0140-6736(91)92978-b. Lancet. 1991. PMID: 1674295 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters